Bandhan Healthcare Fund Direct IDCW
NAV ₹11.543 on 13 November 2026
AMFI name: Bandhan Healthcare Fund - Direct Plan - IDCW · Scheme code 153971
IDCW option: returns are NAV changes and leave out payouts, so they understate what investors received. Risk ratios are not shown for payout options.
Returns
To 13 November 2026. Up to 1 year: total change. 3 and 5 years: compound return a year.
| Period | This fund | NIFTY HEALTHCARE INDEX TRI | Category median |
|---|---|---|---|
| 1M | +7.44% | +8.67% | +8.37% |
| 6M | +11.13% | +12.84% | +10.20% |
| 1Y | - | +38.92% | +5.55% |
| 3Y | - | +28.05% | +16.88% |
| 5Y | - | - | +15.07% |
Benchmark: NIFTY HEALTHCARE INDEX TRI (total return index), measured over the same dates. The scheme document names BSE Healthcare TRI, which we do not hold, so this is the closest NSE index.
Category median: the middle return among Direct plans (Growth option) in AMFI's “Equity Schemes - Sectoral Fund” category, up to 20 funds with clean data. Ranks are under “Rank among peers”.
Rank among peers
Direct plans, Growth option, in AMFI's “Equity Schemes - Sectoral Fund” category. Each rank counts only the peers that have that figure.
| Rank | Scheme Name | 3Y Return | 1Y Return | Sharpe | Direct TER | AUM |
|---|---|---|---|---|---|---|
| #1 | Nippon India Mutual Fund | +46.52% | +60.64% | 1.07 | 1.06% | ₹1,100 Cr |
| #2 | HDFC Mutual Fund | +33.64% | +20.34% | 1.07 | 0.89% | ₹11,128 Cr |
| #3 | HDFC Mutual Fund | +31.28% | +31.60% | 1.76 | 1.03% | ₹3,128 Cr |
| #4 | SBI Mutual Fund | +25.42% | +26.07% | 1.47 | 0.76% | ₹5,565 Cr |
| #5 | HDFC Mutual Fund | +24.77% | +10.10% | 1.09 | 1.10% | ₹1,997 Cr |
| #6 | Mirae Asset Mutual Fund | +24.42% | +27.89% | 1.28 | - | ₹3,458 Cr |
| #7 | UTI Mutual Fund | +23.89% | +22.00% | 1.31 | 1.35% | ₹1,399 Cr |
| #8 | ICICI Prudential Mutual Fund | +22.73% | +10.29% | 0.95 | 2.08% | ₹3,926 Cr |
| #- | Bandhan Healthcare FundCurrent Fund Bandhan Mutual Fund | - | - | - | 1.25% | ₹325 Cr |
Costs and fund facts
- Expense ratio (stated maximum)
- Direct 1.25% · Regular 2.78%
- Exit load
- • If redeemed/switched out on or within 30 days from the date of allotment: 0.50% of the applicable NAV • If redeemed/switched out after 30 days from date of allotment – Nil
- Fund size (all plans)
- ₹325 CrAverage, quarter to September 2026
- Benchmark
- BSE Healthcare TRICompared here with NIFTY HEALTHCARE INDEX TRI
- Launch date
- 10 November 2025AMFI
- Type
- An open-ended equity scheme investing in healthcare, pharma and allied services
- AMFI scheme code
- 153971
Fund managers (3)
- Viraj Kulkarni
- Brijesh Shah
- Ritika Behera and Mr. Gaurav Satra
How each manager has done since taking over: fund manager scorecard.
Investment objective
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors. Disclaimer: There is no assurance or guarantee that the scheme’s objectives will be realised.
From the scheme summary document filed with AMFI.
SIP calculator
A monthly SIP replayed on this fund's actual daily NAVs: what it would be worth today.
IDCW option: values use the NAV only and leave out the payouts, so they understate what an investor received. The Growth option of this fund shows the full return.
About this fund
Bandhan Healthcare Fund Direct IDCW is a mutual fund scheme from Bandhan Mutual Fund, listed by AMFI under “Equity Schemes - Sectoral Fund”. This page covers the Direct plan with the IDCW option. Its NAV was ₹11.543 on 13 November 2026. The fund house rates its risk as “Very High” on the SEBI riskometer. Its average assets under management were ₹325 Cr across all plans for the quarter ending September 2026, as reported to AMFI. Its scheme summary document states a maximum expense ratio (TER) of 1.25% a year for the Direct plan. Managed by Viraj Kulkarni, Brijesh Shah and Ritika Behera and Mr. Gaurav Satra. AMFI lists the scheme's launch date as 10 November 2025.
Figures are calculated from AMFI NAVs and index data, not taken from fund factsheets. Methodology. Past performance is not a guide to future returns.